Sagility India Share Price in Focus as It Declines After Back-to-Back Circuits

Sagility India Limited, a technology-driven healthcare solutions provider, focuses on enabling US-based payers, providers, and their partners to deliver top-tier operations, improved experiences, and high-quality care. 

Share Price Performance

Sagility India’s shares opened higher at ₹54.27 on January 6, 2024, but later traded near the day’s low at ₹51.65, marking a 2.22% decline. In December, the stock touched a high of ₹56.40, and it is currently trading about 5% below its peak. Sagility India made its debut in November 2023 with an IPO price of ₹30, closing with a 3.5% premium. The IPO garnered a decent response, achieving an overall subscription of 3 times. 

The company has demonstrated impressive financial performance and growth, leveraging its expertise in automation and analytics. This article explores Sagility’s Q2 FY25 results, operational highlights, and market performance.

Sagility India Q2 FY25 Financial Performance  

Sagility India Limited delivered robust results in the second quarter of FY25:

• Revenue Growth: Revenue surged to ₹13,250 million, reflecting a 21.1% year-over-year (YoY) increase.
• EBITDA Performance: Adjusted EBITDA grew by 22.2% YoY to ₹3,378 million, driven by improved operational efficiency.
• Profit After Tax (PAT): Adjusted PAT rose by 30.5% YoY to ₹1,636 million.

H1 FY25 Performance 

For the first half of FY25, Sagility maintained steady growth:

• Revenue: ₹25,484 million, up 15.3% YoY.
• EBITDA: Adjusted EBITDA climbed 12.8% YoY.
• PAT: Adjusted PAT increased 15.1% YoY.

Operational and Workforce Updates

• Employee Growth: The company added 2,522 employees during the quarter, increasing its global headcount to 38,380.
• Attrition Rates: Voluntary attrition remained controlled at 25.8%.
• Tech Initiatives: Sagility continued to expand its GenAI initiatives and tech-enabled solutions, focusing on enhancing automation and analytics to drive efficiency and growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.